
This study aims to assess the effectiveness, zzso safety, and patient satisfaction of obesity treatments using the zzso zzso balloon zzso 

Prospective controlled trial of 33 obese patients who were treated with the zzso from March 2008 to March 2009 and who completed the 6 months zzso Patients were selected on the basis of zzso by a multidisciplinary zzso The 33 obese patients zzso zzso seven zzso had a median age of 35 years zzso zzso Their median baseline body weight zzso was 114 zzso zzso zzso and their median body mass index zzso was zzso zzso zzso zzso 

Average weight reduction was 14 zzso zzso zzso loss total weight zzso zzso zzso control zzso zzso zzso zzso zzso delta zzso zzso zzso zzso percentage excess weight loss zzso zzso zzso and percent of excess zzso loss zzso zzso zzso In one female patient the zzso was removed early due to zzso During the first week, minor side effects were zzso zzso occurred in 21 patients zzso and abdominal zzso in 15 zzso There was one balloon zzso and one zzso in the zzso Those incidents were both successfully treated zzso Patients had no major complications from zzso zzso and no need for surgical zzso All zzso balloons were successfully removed zzso zzso treatment satisfaction correlated with the degree of zzso loss zzso 

zzso treatment in our setting showed the best results for individuals with zzso from 35 to 40 zzso Our preliminary results showed that zzso is safe, well tolerated with minor side effects, and alters quality of life for the zzso The complication rate was zzso due to the detailed zzso examinations and zzso 

